Skip to content
← Back to this collection

PUBLICATIONS · 32822286

MILO/ENGOT-ov11: Binimetinib Versus Physician's Choice Chemotherapy in Recurrent or Persistent Low-Grade Serous Carcinomas of the Ovary, Fallopian Tube, or Primary Peritoneum.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2020 Nov 10
First author
Monk BJ

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2020 Nov 10;38(32):3731-3734. doi: 10.1200/JCO.20.02190.
    note
    Source null
    related pmid
    32897828
    relationship
    Comment in

Authors and identifiers

  1. name
    Monk BJ
    type
    Author
  2. name
    Grisham RN
    type
    Author
  3. name
    Banerjee S
    type
    Author
  4. name
    Kalbacher E
    type
    Author
  5. name
    Mirza MR
    type
    Author
  6. name
    Romero I
    type
    Author
  7. name
    Vuylsteke P
    type
    Author
  8. name
    Coleman RL
    type
    Author
  9. name
    Hilpert F
    type
    Author
  10. name
    Oza AM
    type
    Author
  11. name
    Westermann A
    type
    Author
  12. name
    Oehler MK
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Monk BJ
    type
    Author
  2. name
    Grisham RN
    type
    Author
  3. name
    Banerjee S
    type
    Author
  4. name
    Kalbacher E
    type
    Author
  5. name
    Mirza MR
    type
    Author
  6. name
    Romero I
    type
    Author
  7. name
    Vuylsteke P
    type
    Author
  8. name
    Coleman RL
    type
    Author
  9. name
    Hilpert F
    type
    Author
  10. name
    Oza AM
    type
    Author
  11. name
    Westermann A
    type
    Author
  12. name
    Oehler MK
    type
    Author
bibliography ids
  1. nci-bib-114ecd4324896a386bcff909
book metadata
content sha256
4035173d2d40879bfb88ee95581a8a6d8a4c7c6127fa75e1399ed1ecdb769e91
document type
citation
dois
  1. 10.1200/JCO.20.01164
electronic publication date
display
2020 Aug 21
precision
day
year
2020
evidence scope
bibliographic_metadata_only
id
pubmed:32822286
immutable id
pubmed:32822286@4035173d2d40879bfb88ee95581a8a6d8a4c7c6127fa75e1399ed1ecdb769e91
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
32
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
3753-3762
volume
38
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2020 Nov 10;38(32):3731-3734. doi: 10.1200/JCO.20.02190.
    note
    Source null
    related pmid
    32897828
    relationship
    Comment in
outcomes validated
false
pmid
32822286
provenance
batch id
40d9eae1f1d369f13109
provider
NCBI PubMed ESummary
record sha256
6d09c0ac29afe3c527613f3aaa36b49a96f4a89e91e6b92c3fedf79bb4a6fad0
response sha256
03fa1567b6babd78281d8ec4529596b9d4953c2c4ac23257dca371d609645ba9
retrieved at
2026-09-09T23:47:52.637547+00:00
publication date
display
2020 Nov 10
precision
day
year
2020
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, N.I.H., Extramural
  6. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/32822286/
title
MILO/ENGOT-ov11: Binimetinib Versus Physician's Choice Chemotherapy in Recurrent or Persistent Low-Grade Serous Carcinomas of the Ovary, Fallopian Tube, or Primary Peritoneum.

Preserved source evidence · Not medical advice